Lexicon Pharmaceuticals, Inc. (LXRX)

Last Closing Price: 0.63 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Lexicon Pharmaceuticals, Inc. (LXRX) had Net Income of $-200.40M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$31.08M
Net Income
$-200.40M
$0.62M
$30.46M
$228.20M
$-197.12M
$-3.29M
$-200.40M
$-200.40M
$-200.40M
$-200.40M
$-200.40M
$-200.40M
$-197.12M
$-194.74M
320.03M
320.03M
$-0.63
$-0.63
Balance Sheet Financials
$246.19M
$2.48M
$52.23M
$298.42M
$45.25M
$100.30M
$107.22M
$152.47M
$145.95M
$101.41M
$145.95M
361.49M
Cash Flow Statement Financials
$-178.78M
$-15.38M
$238.35M
$22.46M
$66.66M
$44.19M
$13.50M
--
--
Fundamental Metrics & Ratios
5.44
--
--
0.41
0.69
98.02%
-634.20%
-634.20%
-626.55%
-644.78%
-644.78%
$-179.81M
--
--
--
0.10
2.67
8.95
40.79
-137.31%
-197.62%
-67.15%
-81.38%
$0.40
$-0.56
$-0.56